¹æ±¤¾Ï ȯÀÚ¿¡¼ÀÇ ¹æ±¤Á¡¸· ºñ¸¸¼¼Æ÷ÀÇ ¹ÝÀÀ
Bladder Mucosal Mast Cell Response in Bladder Tumor
¼Ò¼Ó »ó¼¼Á¤º¸
±âµ¿¼®/Dong Seok Ki
±èÇÏ¿µ/¹Ú³²Á¾/¼±Èñ¼®/±èűÔ/Ha Young Kim/Nam Jong Park/Hi Sug Sun/Tae Kyu Kim
KMID : 0358319970380101059
Abstract
¼·Ð
ºñ¸¸¼¼Æ÷´Â µÕ±Ù ÇÙ°ú ´Ù·®ÀÇ ÀÌ»ö¼º (metachromasia)¼¼Æ÷Áú °ú¸³À» ÇÔÀ¯ÇÏ´Â ÁÖ·Î ¸ð¼¼
Ç÷°üÁÖÀ§¿¡ Á¸ÀçÇÏ´Â ¿øÇü ¶Ç´Â ¹æÃßÇüÀÇ ¼¼Æ÷À̸ç Å©°Ô Á¡¸·ºñ¸¸¼¼Æ÷¿Í °áüÁ¶Á÷ºñ¸¸¼¼Æ÷
·Î ³ª´©¾îÁø´Ù. ÀÌ ¼¼Æ÷´Â ¿°Áõ¼º Áúȯ, ¾Ë·¹¸£±â¼º Áúȯ ¹× ¿©·¯ Á¾·ùÀÇ Á¾¾çµé¿¡¼µµ Áõ°¡
ÇÑ´Ù. ±â´ÉÀÌ ¸¹ÀÌ ¹àÇôÁöÁö ¾Ê¾ÒÁö¸¸ histamine, heparin µîÀÇ ¿©·¯ ¸Å°³¹°Áú (mediators)¹×
Áß¿äÇÑ cytokines À» »ý»êÇÏ¿© ¸é¿ª ¹ÝÀÀ¿¡µµ °ü¿©ÇÏ´Â ¼¼Æ÷ÀÌ´Ù.
»ýÁãÀÇ µ¿¹°½ÇÇè¿¡¼ Á¾¾ç À̽ÄÈÄ ¼÷ÁÖÀÇ °¡Àå Ãʱ⠹ÝÀÀÁß Çϳª°¡ Á¾¾ç ÁÖÀ§ÀÇ ºñ¸¸¼¼Æ÷
ÀÇ ¼ýÀû Áõ°¡ÀÌ´Ù. ÀÌ¿Í °°Àº ¹ÝÀÀÀº Á¾¾ç ÀÌ½Ä ÈÄ Ã¹Â° ³¯¿¡ ÀϾ´Â °ÍÀ̸ç, ÀÌÈÄ ´Ù¾çÇÑ
¿°Áõ¼¼Æ÷µéÀÇ ÃàÀûÀÌ ÀÌ·ç¾îÁø´Ù. Á¾¾ç ÁÖÀ§ÀÇ ºñ¸¸¼¼Æ÷ÀÇ ÃàÀûÀº Á¾¾çÀÇ ÈÇÐÀ¯Àι°Áú¿¡
ÀÇÇÑ ÀǵµÀûÀÎ À̵¿À¸·Î º¸À̳ª ÀϺΠÁ¾¾ç¿¡ ´ëÇÑ ºñ¸¸¼¼Æ÷ ¹ÝÀÀÀÇ ±× ±â´ÉÀû ¿ªÇÒ¿¡ ´ëÇÏ
¿©´Â ¿©·¯ÇÐÀÚµéÀÌ »ó¹ÝµÈ °ßÇØÀÇ ÁÖÀåµéÀ» Á¦±âÇÏ°í ÀÖ´Ù. Áï ºñ¸¸¼¼Æ÷°¡ TNF µîÀÇ
cytokinesÀ» ÅëÇÑ Á÷Á¢ÀûÀÎ ºñ¸¸¼¼Æ÷ Áß°³¼º Á¾¾ç¼¼Æ÷ µ¶ÀÛ¿ëÀ» º¸ÀÏ »Ó ¾Æ´Ï¶ó Á¾¾çÀÇ °¨
½Ã¿Í ¾ïÁ¦ÀÇ ±â´ÉÀ» °¡Áö°í ÀÖ´Ù´Â º¸°íµéÀÌ ÀÖ´Â ¹Ý¸é ºñ¸¸¼¼Æ÷°¡ Å»°ú¸³ (degranulation)
°ú ¼¼Æ÷¿Ü À¯Ãâ (exocytosis) °úÁ¤À» ÅëÇØ ¿©·¯°¡Áö ¸Å°³¹°ÁúÀ» ºÐºñÇϹǷμ ±³¿øÁú¿ëÇØ
(couagenolysis)¿Í ½Å»ý¸ð¼¼Ç÷°ü»ý¼º¿¡ °ü¿©ÇÏ¿© Á¾¾çÀÇ ¹ßÀ°, ÁøÇà, ÀüÀÌ¿¡µµ °ü¿©ÇÒ °ÍÀÌ
¶ó´Â ÁÖÀåµµ ÀÖ´Ù. ÀÌ¿Í °°ÀÌ ½ÇÇè µ¿¹°¿¡¼ Á¾¾ç ºÎÀ§¿¡¼ÀÇ ºñ¸¸¼¼Æ÷ÀÇ ±â´ÉÀû ¿ªÇÒ¿¡ ´ë
ÇÏ¿©´Â ¸¹Àº ³í¶õÀÌ ÀÖÀ¸³ª ÀÎü Á¾¾ç¿¡¼ÀÇ ºñ¸¸¼¼Æ÷ÀÇ ¿ªÇÒ¿¡ ´ëÇؼ´Â ÇöÀç±îÁö º°´Ù¸¥
¿¬±¸³ª º¸°í°¡ ¾ø´Â ½ÇÁ¤ÀÌ´Ù.
#ÃÊ·Ï#
Mast cells are immune-mediators producing cells and involved in neovascularization of
some tumors. Such roast cell is divided into two cell types: mucosal mast cell and
connective tissue mast cell. There are controversies about the roles of mast cells in
suppression and metastasis of some tumors (including bladder tumor). We performed
bladder mucosal biopsies in 28 patients (from September 1994 to July 1996) and
observed bladder mucosal mast cell responses in bladder tumor (TCC) under toluidine
blue stain ( 400). Patients were divided into 2 groups: group A was consisted of
bladder tumor patients (21 cases), whereas group B was the control group (7 cases).
Mast cell responses, average mucosal mast cell counts in high power field, in group A
and B were 1.75¡¾0.25 cells/HPF, 0.29¡¾0.20 cel1/HPF respectively. We observed more
mast cell responses in bladder tumor patients group. But fundamental researches will be
needed to elucidate the causes of mast cell activation in bladder tumor.
Å°¿öµå
Mast cell; Bladder tumor;
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸